Further stratification of IPMN lesions (according to expression profile of Muc1, Muc2, and Muc5) into intestinal, gastric and pancreatobiliary types23 revealed Notch incidences of 46%, 79%, and 33%, respectively. This evidence concerns the gene MUC1 and pancreatic intraductal papillary-mucinous neoplasm.